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ABSTRACT
Objective: To explore clinicians views of the barriers
and facilitators to use of C-reactive protein (CRP)
point-of-care tests (POCT) in US family medicine
clinics for the management of acute respiratory tract
infections (ARTIs) in adults.
Setting: Five family medicine clinics across two US
states.
Participants: 30 clinicians including 18 physicians, 9
physician residents, 2 physician assistants and 1 nurse
practitioner, took part in the study.
Design: A qualitative study using a grounded theory
approach to thematically analyse focus group
interviews.
Results: These clinicians had limited access to
diagnostic tests for patients with ARTI, and very little
knowledge of CRP POCT. Three major themes were
identified and included the potential clinical role of
CRP POCT, concerns related to implementing CRP
POCT and evidence needed prior to wider adoption in
family medicine. Clinicians believed CRP POCT could
support decision-making for some presentations of
ARTIs and patient populations when used in
conjunction with clinical criteria. Clinicians had
concerns about possible overuse and inaccuracy of
CRP POCT which they believed might increase
antibiotic prescribing rates. Other concerns identified
included integration of the test with clinic workflows
and cost-effectiveness.
Conclusions: Clinicians stand at the forefront of
antibiotic stewardship efforts, but have few diagnostic
tests to help them confidently manage ARTIs. CRP
POCT may facilitate some aspects of clinical practice.
Incorporating CRP POCT with clinical guidelines may
strengthen utility of this test, when there is diagnostic
uncertainty.
INTRODUCTION
Acute respiratory tract infections (ARTIs) are
one of the most common reasons for adults
presenting to primary care settings in the
USA.1 2 For ARTIs such as acute bronchitis,
sinusitis and pharyngitis that are predomin-
antly viral, antibiotics confer little or no
benefit for reducing risks of serious compli-
cations, nor significantly reduce time to
symptom resolution.3 Yet reportedly between
2007 and 2009, ∼51% of adult patients were
prescribed antibiotics unnecessarily for these
types of ARTIs4 and more recently 67.8% of
patients presenting to outpatient settings
were reported as using antibiotics for
acute bronchitis.5 Diagnostic and prognostic
uncertainties, due to overlapping signs and
symptoms between bacterial and viral infec-
tions6 and perceived patient demand for
antibiotics, have been identified as drivers of
inappropriate antibiotic prescribing.7–9 Overuse
of antibiotics is associated with the emer-
gence of antibiotic-resistant microorganisms,
Strengths and limitations of this study
▪ This is the first study to explore clinician atti-
tudes towards C reactive protein point-of-care
tests (CRP POCT) for acute respiratory infections
in adults in US primary care settings.
▪ Potential barriers and facilitators of future imple-
mentation of CRP POCT in the USA related to
clinical utility of this test are highlighted, as well
as organisational and financial arrangements that
need to be addressed in order for CRP POCT to
be integrated into clinical practice and family
medicine clinics.
▪ Clinicians had limited knowledge and experience
of CRP POCT, in any type of healthcare setting.
Consequently, attitudes presented in this study
may have been influenced by the description of
CRP POCT given by interviewers, rather than
from working knowledge of the test.
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which can cause treatment failure,10 and heighten risk
of future adverse events.11 Escalating prevalence of anti-
microbial resistance coupled with slow development of
new antibiotics12 means identifying interventions to
encourage judicious prescribing is a national and global
priority.
Over the last 20 years, there have been numerous
attempts in the USA to reduce inappropriate prescrib-
ing; these include the Centers for Disease Control and
Prevention’s (CDC) ‘Get Smart: Know When Antibiotics
Work’ initiative in 199513 and more recently the
‘Choosing Wisely’ campaign from the American Board
of Internal Medicine Foundation.14 While reduced pre-
scribing rates have been reported for children, antibiotic
use has remained static in adults and actually increased
in older adult populations (≥65 years).15 C-reactive
protein (CRP) is a biomarker of systemic inflammation
that quantifies serum CRP from a finger-prick blood
sample within 4 min,16 with levels typically more elevated
during bacterial than viral infections.17 CRP
point-of-care tests (POCT) used as part of the clinical
assessment for ARTI may help clinicians better discern
patients with bacterial aetiology, and thus which patients
would benefit from antibiotics.18 19 Robust evidence
from two meta-analyses found that CRP POCT was sig-
nificantly associated with reduced antibiotic prescribing
for ARTIs at the initial patient visit.20 21 CRP POCT is
used routinely in clinical practice in some European
countries, but is not widely used in family medicine in
the USA.22 In this qualitative study, we explore the
potential acceptability to family medicine clinicians of
using CRP POCT as part of the clinical workup for
adults with ARTIs in US primary care.
METHODS
Subjects
Family medicine clinicians were recruited from five
clinics in the Washington, Wyoming, Alaska, Montana
and Idaho (WWAMI) region Practice and Research
Network (WPRN). The WPRN is a network of over 50
community-based primary care practices across the
five-state WWAMI region. Participants were recruited on
convenience (either in person or via email) on behalf
of the research team, by clinician research champions
whose role is to engage clinic staff in WPRN research
activities at each site. Clinics were selected based on type
(eg, community health centres and hospital-affiliated),
location (eg, urban, rural) and clinical interest, to
recruit clinicians with a broad range of experiences and
perspectives. Participants received written information
and gave verbal consent before discussions began. As an
early review of the literature had revealed no US-based
studies on CRP POCT in US family medicine, the inter-
viewer(s) gave a brief description of CRP POCT and the
primary condition of interest (ie, ARTIs) to familiarise
participants (see online supplementary file 1). The
study proposal was reviewed by the University of
Washington’s Human Subjects Division Institutional
Review Board and given an exempt determination (ref-
erence 49929).
Focus groups
Audio-recorded focus groups lasting 40–50 min were
conducted with participants at each clinic by a family
physician (MT) or a non-clinical researcher (VH). Both
interviewers’ research background is in the use of diag-
nostic to improve the recognition of infectious diseases.
A topic guide developed by the research team was used
to guide discussions. Semistructured questions explored
opinions about using on-site diagnostic tests to guide
antibiotic prescribing, prior experience or knowledge of
CRP POCT and attitudes towards use of CRP POCT for
adults with suspected ARTIs. Topic guides were
informed by literature relating to general use of POCT
in primary care,23 with a specific focus on CRP POCT
for ARTIs,24 and were reviewed and revised following
input from our research champions prior to use.
Further questions were added to the topic guide as
themes emerged from successive focus groups (see
online supplementary file 1). At the end of each focus
group, participants completed a brief anonymous survey
to provide descriptive characteristics. Data collection
took place between August and December 2015.
Data analysis
Data analysis began after the first interview had been
transcribed. Transcripts were initially read to gain an
overall impression of subjects’ attitudes, and codes
manually annotated in margins. Transcripts were then
examined and reflected on to challenge initial data
interpretation, and to more formally synthesise themes
and subthemes to which segments of text were assigned.
Using the constant comparison method influenced by
grounded theory, themes were derived inductively and
data were cyclically contrasted for ‘fit’. Relationships
between themes were validated or modified as interviews
progressed.25 A coding framework was developed by one
author (VH), discussed and revised by another (MT)
and reviewed by all authors to verify description and
grouping of themes reflected the data; minor modifica-
tions were made based on feedback from a third author
( JN). Qualitative software, Nvivo V.10, was used to facili-
tate data organisation.
RESULTS
A total of 30 clinicians participated from the five clinics.
Eighteen (58%) were family physicians, nine (31%)
family physician residents, as well as two physician assis-
tants and one nurse practitioner (one family physician
did not complete the written survey due to time con-
straints) (table 1). Three major themes were identified:
(1) potential clinical role of CRP POCT; (2) concerns
related to implementation and (3) evidence needed
prior to use of CRP POCT in family medicine clinics,
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discussed below. Additional quotations supporting themes
are provided in online supplementary file 2 (quotes are
protected using participant (C)/site codes (S))
Most participants had experience of using CRP as a
send-out laboratory test for rheumatological conditions
and suspected sepsis, but few had knowledge or experi-
ence of CRP POCT for the workup of ARTIs, in any
healthcare setting. Participants used rapid group A
streptococcal tests to guide antibiotic prescribing for
sore throat and some had also used procalcitonin for
suspected pneumonia and sepsis in inpatient settings.
Other diagnostic tests (including send out) for ARTIs in
adults were reported as being rarely used, although
occasionally chest radiography and white cell count were
used.
Potential clinical role(s) of point-of-care CRP
Participants mostly described feeling confident knowing
when to prescribe antibiotics, and equally when to with-
hold them, when patients’ infections (or their percep-
tion that it was severe or bacterial) could be clearly
dichotomised into present or absent. However, they
identified a need for diagnostic assistance in the
“middle cases” (P5, S3) where aetiology is not reliably
discerned from patients’ symptoms, or where there is
uncertainty about the ‘window of opportunity’ in the
time course of a patient’s illness within which an anti-
biotic would be beneficial, “like that sinus infection at
six and a half days, where you’re not sure” (P3, S5), and
for which “guidelines fail me” (P3, S2). Participants also
described diagnostic uncertainty for patients at
increased risk of complications, such as those with acute
infective exacerbations of chronic obstructive pulmonary
disease and asthma; scenarios which were believed to
more likely result in precautionary antibiotic prescribing
for patient safety reasons (Q1), and for which they
noted that CRP POCT could play a role in clinical
practice.
Generally, participants believed expectations for anti-
biotics had abated over recent years (Q2), with two
noting that patients seem relieved “that I [the provider]
am not just turning to antibiotics” (P4, S1). However,
clinicians continued to perceive pressure for antibiotics
from a subgroup of patients, including those with whom
clinicians did not have a relationship, parents of young
children or patients whom they believed had been given
antibiotics unnecessarily in the past for similar (self-
limiting) illnesses. For these patients, not prescribing
was described as sometimes more difficult and time con-
suming than simply prescribing (Q3). Having a visible
test result to share with unconvinced patients during the
patient visit might reassure patients that clinicians were
making appropriate treatment decisions, “because some-
times I think they think we are just guessing” (P4, S1).
Equally, a test such as this was viewed as affording an
opportunity to share the justification underpinning anti-
biotic prescribing decisions with patients, which might
make them aware of the “complexity and lack of clarity
about medical decision-making”, that “doctoring is
hard” (P3, S1), and understand that a ‘no prescribing
decision’ does not mean their concerns are being dis-
missed (Q4). Therefore, for “select patients it [CRP
POCT] could be a valuable tool” (P3, S5).
Concerns related to implementation
Participants expressed concerns about the risk of falsely
elevated results in patients with underlying inflammatory
conditions and for whom CRP POCT might not be
appropriate to use (eg, rheumatoid arthritis) (Q5), and
the consequences of getting a false negative result in the
presence of serious bacterial infections (Q6). High false
positive rates for bacterial aetiology could increase anti-
biotic prescribing, especially as “clinics become more
efficient, then all of a sudden the test is being done
automatically” (Q7). “Having the patient present with
this [respiratory complaint] and the MA [medical assist-
ant] just does the CRP”(P2, S3) before the patient has
been clinically assessed may pressurise clinicians into
treating with antibiotics in situations where they later
believe the result to be falsely positive, increasing anti-
biotic prescribing rates (Q8). Participants emphasised
CRP POCT should supplement clinical findings: “We
should be using our clinical skills to come up with what
we think is the right diagnosis. We should only be using
the test to confirm or refute the diagnosis” (P1, S3). Not
giving more precedence to CRP POCT over time might
be challenging and resident physicians were worried
they might come to depend on the test to the detriment
of developing clinical skills. A small number of partici-
pants identified the risk of medicalising self-limiting ill-
nesses through unnecessary use of CRP POCT which
they believed might increase patient demand for diag-
nostic testing in future encounters (Q9).
There were mixed opinions about how CRP POCT
could be integrated into clinic workflows. Participants at
one clinic had concerns about the time that would be
needed to administer and interpret the test, primarily
related to clinics’ testing processes (Q10). For example,
POCTs that are conducted in on-site laboratories,
involve the patient leaving the examination room to get
Table 1 Participant characteristics, N=30
Characteristics n (%)
Type of practitioner
Faculty/staff physician 18 (58.6)
Resident physician 9 (31)
Physician assistant 2 (6.9)
Nurse practitioner 1 (3.4)
Gender
Male, n (%) 16 (55.2)*
Mean age in years (range) 46.9 (27–70)*
Mean years at clinic (range) 8.6 (0.08–38)*
*Excludes descriptive data for one family physician who did not
complete the survey.
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the test and then returning. Participants at one clinic
viewed this as an impediment to implementation
because “it changes a 15-minute encounter into a
55-minute process, which is a disincentive to get any
diagnostic test” (P3, S5). In contrast, others believed if it
“saved counselling people out of antibiotics” (P6, S3)
then it could save time.
Without knowing reimbursement rates and patient
out-of-pocket costs of CRP POCT which were noted to
vary depending on the types of insurance coverage at
clinics (ie, private insurance, Medicare/Medicaid) as
well as overall cost-effectiveness, participants were uncer-
tain about the financial viability of using CRP POCT
(Q11). One clinic which subsidised the cost of antibio-
tics at their pharmacy, felt use of CRP POCT could offset
the high costs of some antibiotics (Q12).
Evidence needed prior to implementing
Participants held mixed views on the overall impact of
CRP POCT on antibiotic prescribing rates, which were
linked to clinicians’ general understanding of CRP, per-
ceived discriminatory value, beliefs about the helpful-
ness of CRP POCT for counselling patients and how the
test would be used (or overused). Some believed “it
would […] without a doubt lower antibiotic prescribing”
(P3, S2) while others were “not sure the CRP test would
decrease the number of antibiotic prescriptions” (P2,
S5). Therefore, evidence related to the clinical effective-
ness of CRP POCT in reducing antibiotic use “[if] on a
national or large level [CRP POCT] brought down anti-
biotic use. That would be really alluring” (P2, S5), was
desired. Participants described the need for data from
robustly designed studies, “RCTs would be best” (P3,
S3). There was a particular desire for clinical studies that
are generalisable to US populations (Q15), because “you
can’t compare apples to oranges when you’re dealing
with a study in Scandinavia where they don’t have dia-
betes, they’re not homeless” (P4, S2). Additionally, diag-
nostic accuracy information showing false positive and
false negative rates of CRP POCT and CRP levels in bac-
terial and viral infections, including how quickly levels
become elevated (and how high and for what duration)
during the course of ARTI, would be beneficial to help
them interpret test results (Q13; Q14). Finally, data that
could be applied to Native American populations who
they considered at higher risk of complications from
ARTIs and for whom clinicians “treat outside the typical
window” (P3, S2) were identified as a need.
DISCUSSION
Key findings
Family medicine clinicians currently have a limited
number of diagnostic tests in their arsenal to help dis-
criminate between bacterial and viral ARTIs in adults.
Despite convincing evidence supporting the use of CRP
POCT for ARTIs in primary care settings, and their
routine clinical use in many European countries,26
surprisingly few clinicians had knowledge of this test,
and most had never used CRP POCT in primary or sec-
ondary care. Overall, CRP POCT was acceptable to clini-
cians who believed for defined patient populations and
clinical scenarios (eg, where there was lingering uncer-
tainty, perceived patient pressure or for patients at ele-
vated risk of developing complications), CRP POCT if
used as an adjunct to clinical assessment, could be used
to support patient counselling efforts, and improve anti-
biotic prescribing decisions for ARTIs; although they
were undecided about the overall impact of CRP POCT
on national prescribing rates. Clinicians were concerned
about inaccuracy and usefulness of CRP POCT in the
context of patients with inflammatory comorbidities who
are more likely to falsely test positive, overprescribing
precipitated by overtesting leading to undermining of
clinicians’ skills and encouraging future patient demand
for diagnostic tests and cost-effectiveness.
Comparison with existing literature
A systematic review of qualitative studies (none from the
USA) on clinicians’ perceptions of POCT blood testing
(eg, CRP, haemoglobin A1c) in primary care, identified
similar findings to ours specific to CRP POCT, including
improved confidence in decision-making in certain clin-
ical scenarios, worry of inaccurate results and concern
over-reliance on diagnostic tests might undermine clini-
cian’s clinical skills.23 Also consistent with our study,
Jones et al reinforce the diagnostic need for discerning
bacterial from viral aetiology, particularly in situations
where signs and symptoms fail to provide sufficient dis-
criminatory value. As CRP values at extreme ends of the
spectrum typically allow aetiology to be better dis-
cerned27 than do values that are intermediately ele-
vated,28 reconciling this diagnostic need with the
potential uncertainty of CRP as a marker for patients at
intermediate risk of adverse outcomes, needs to be
balanced. While some diagnostic uncertainty in clinical
practice may be unavoidable,27 in these scenarios diag-
nostic certainty might be enhanced in the USA by incorp-
orating CRP POCT into clinical guidelines (such as the
National Institute for Health and Care Excellence
(NICE) guidelines for pneumonia in the UK22), that
recommend when CRP POCT is appropriate, as well as
the threshold value/range indicating rational prescrib-
ing of antibiotics. Indeed, use of CRP POCT in conjunc-
tion with the clinical assessment for the diagnostic
workup of ARTIs,29 and for enhancing patient commu-
nication16 has been expressed by clinicians elsewhere in
the literature, as well as in our findings. Although not
significantly changing the proportion of patients falling
into the intermediate-risk category, adding CRP POCT
to the clinical assessment has been reported to improve
accurate discrimination of patients with and without
pneumonia (ie, increased true positive and negative
results), potentially improving the reliability of diagnos-
tic information available to clinicians.30
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Additionally, in many family medicine clinics, MAs are
the first person to see the patient. With more POCTs
being given a Clinical Laboratory Improvement
Amendment (CLIA)-waived determination (ie, limited
complexity to implement/interpret and low risk of erro-
neous results) (eg, Rapid Strep),31 MAs may be poised
to undertake more of this type of testing in the future.
Our findings underscore a lack of clarity about how
delivery of CRP POCT would be optimised in family
medicine clinics. Mixed views about how CRP POCT
(and POCT more generally) would be integrated into
clinic workflows, specifically, who will perform the
testing and when, coincides with existing research.16 32
Uncertainty about the cost-effectiveness of POCT has
been repeatedly cited as a constraint to broader imple-
mentation, supported by our findings.33 34
Strengths and limitations of the study
This is the first study to explore US clinician’s knowl-
edge and attitudes about use of POCT CRP for clinical
management of ARTI, which is relevant to stakeholders
nationally for considering the role existing diagnostic
technologies could play in strengthening frontline anti-
biotic stewardship efforts. We collected data from clini-
cians at different types of family medicine clinics, which
broadened the scope of issues elicited. Data collection
ended after the fifth focus group due to thematic satur-
ation, which is consistent with qualitative standards when
using focus groups for data collection with homogenous
participants.35 Focus groups were facilitated by a family
physician with experience evaluating diagnostic tests for
infectious diseases. To ensure discussions were balanced
and guided by emergent issues, a second (non-clinical)
researcher was present for four of the focus groups, and
also led data analysis. As most clinicians had limited
knowledge of CRP POCT, attitudes could have been
influenced by the description given by interviewers.
Although care was taken not to present opinions/knowl-
edge biasing responses, different attitudes might have
been provoked if participants had first-hand experience
of this test.
Implications for clinicians, researchers and industry
Although the repertoire of diagnostic tests available to
clinicians is expanding, relatively few POCT appear to be
routinely used in family medicine to guide antibiotic
prescribing decisions for ARTIs. Antibiotic stewardship
efforts need to be multifaceted (eg, encompassing
public education strategies, clinician counselling skills),
but our study suggests there remains an unmet diagnos-
tic need36 for a wider range of POCT to be added to the
diagnostic workup of ARTIs in the USA to facilitate the
safe reduction of antibiotics for infections not enabling
a clear ‘rule in/out’ decision. Recognising this perennial
need, a White House report has endorsed prioritising
the development and implementation of point-of-care
diagnostic technologies that facilitate better identifica-
tion of infectious agents to enable pathogen-targeted
treatment, further reducing unnecessary antibiotic pre-
scribing; a strategy that has been promoted and incenti-
vised internationally (ie, the Longitude Prize).37 38 In
the USA, this will require a dialogue between technology
developers, researchers and clinician stakeholders to
ensure the features of POCT are harnessed to fulfil clin-
ical needs39; evaluating the diagnostic and prognostic
value of existing technologies (including CRP POCT)
through rigorous clinical trials40 that include popula-
tions such as American Indians and Alaskan Natives
with greater risk of hospitalisation and mortality from
ARTIs than the general US population,41 and who are
not currently represented in existing European trial
data; collaborating with stakeholders to develop an
implementation plan assisting integration into clinical
practice,39 and determining tests’ cost-effectiveness. As
CRP results cannot be dichotomised, ambiguity ruling
out infections in diagnostic grey areas may persist
without clear guidance for clinicians on how to assimi-
late CRP POCT results with clinical assessment findings
in a meaningful way. Understanding the added informa-
tion provided by CRP POCT results in scenarios where
there is diagnostic uncertainty, could enhance utility of
this test.30
CONCLUSION
CRP POCT was acceptable to clinicians for supporting
decision-making related to ARTIs in certain clinical
scenarios and patient populations. To improve diagnos-
tic certainty and assuage clinicians’ concerns regarding
the effects of unnecessary testing and potential inaccur-
acy, utility of CRP POCT in US family medicine may be
strengthened by clinical guidelines indicating when CRP
POCT is indicated and antibiotic therapy justified.
Determining how to integrate this test into clinic work-
flows along with cost-effectiveness will also be important
for wider adoption in the USA.
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